NDAC
This article was originally published in The Tan Sheet
Executive Summary
Committee meeting slated for Feb. 28-29 canceled and tentatively rescheduled for March 29. No agenda has been announced. The FDA committee's Dec. 2-3 meeting was canceled due to a lack of agenda items. Additional meeting dates in 2000 are June 22-23, Oct. 19-20 and Dec. 7-8. FDA is recruiting to fill vacancies on the committee
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning